Color Genomics' Color Test

Color Genomics has launched the Color Test, a new hereditary cancer risk assessment test. The panel analyzes 30 genes:  BAP1, MITF, CDK4, CDKN2A, ATM, CDH1, NBN, CHEK2, PTEN, BRCA1, BRCA2, PALB2, BARD1, BRIP1, TP53, STK11, MLH1, MSH2, EPCAM, MSH6, PMS2, RAD51C, RAD51D, APC, BMPR1A, SMAD4, GREM1, MUTYH, POLD1, POLE. These genes affect hereditary cancer risks for breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers in both men and women. The company said it has validated the test in studies with the University of Washington and the University of California, San Francisco.